These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

40 related items for PubMed ID: 9082503

  • 1. [Second line chemotherapy in patients with refractory and resistant non small cell lung cancer].
    Jacoulet P, Dubiez A, Westeel V, Polio JC, Pernet D, Depierre A.
    Rev Mal Respir; 1997 Jan; 14(1):29-35. PubMed ID: 9082503
    [Abstract] [Full Text] [Related]

  • 2. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 3. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 4. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Westeel V, Quoix E, Moro-Sibilot D, Mercier M, Breton JL, Debieuvre D, Richard P, Haller MA, Milleron B, Herman D, Level MC, Lebas FX, Puyraveau M, Depierre A, French Thoracic Oncology Collaborative Group (GCOT).
    J Natl Cancer Inst; 2005 Apr 06; 97(7):499-506. PubMed ID: 15812075
    [Abstract] [Full Text] [Related]

  • 5. [Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
    Cok G, Göksel T, Soyer S, Atil H, Güzelant A, Aysan T.
    Tuberk Toraks; 2006 Apr 06; 54(2):161-7. PubMed ID: 16924573
    [Abstract] [Full Text] [Related]

  • 6. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Soh LT, Tan EH, Ang PT.
    Singapore Med J; 1998 Aug 06; 39(8):357-8. PubMed ID: 9844496
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
    Socinski MA, Schell MJ, Bakri K, Peterman A, Lee JH, Unger P, Yates S, Hudgens S, Kies MS.
    Cancer; 2002 Sep 15; 95(6):1265-73. PubMed ID: 12216094
    [Abstract] [Full Text] [Related]

  • 9. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A, Perrone MA, Michiara M, Delnevo D, Franciosi V, Di Blasio B, Ceci G, Camisa R, Ardizzoni A, Cocconi G.
    Cancer; 2005 May 15; 103(10):2109-17. PubMed ID: 15803492
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep 15; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 11. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
    Mantovani G, Macciò A, Mulas C, Massa E, Madeddu C, Mura L, Contu P, Versace R.
    Oncol Rep; 2002 Sep 15; 9(3):661-70. PubMed ID: 11956647
    [Abstract] [Full Text] [Related]

  • 12. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.
    Lung Cancer; 2005 Apr 15; 48(1):129-35. PubMed ID: 15777980
    [Abstract] [Full Text] [Related]

  • 13. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 14. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP, Dafni UG, Malamos NA, Rigatos S, Kouvatseas G, Moschopoulos N.
    Anticancer Res; 1999 Apr 10; 19(4C):3543-8. PubMed ID: 10629650
    [Abstract] [Full Text] [Related]

  • 15. Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
    Perez EA, Gandara DR.
    Semin Oncol; 1994 Jun 10; 21(3 Suppl 4):2-5. PubMed ID: 8209273
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin].
    Donnay Candil O, Jiménez Berlana U.
    Rev Esp Oncol; 1983 Jun 10; 30(4):603-10. PubMed ID: 6100970
    [Abstract] [Full Text] [Related]

  • 17. New directions in non-small cell lung cancer.
    Gralla RJ.
    Semin Oncol; 1990 Aug 10; 17(4 Suppl 7):14-9. PubMed ID: 2166345
    [Abstract] [Full Text] [Related]

  • 18. [Possibilities of chemotherapy in patients with bronchial cancer].
    Hossfeld DK, Zschaber R, Gatzemeier U, Koschel G, Kaukel E, Heilmann HP.
    Rontgenblatter; 1988 Mar 10; 41(3):113-6. PubMed ID: 2838891
    [Abstract] [Full Text] [Related]

  • 19. High-dose or dose-intensive chemotherapy for non-small cell carcinoma of the lung.
    Feld R.
    Semin Oncol; 1994 Feb 10; 21(1 Suppl 1):33-7. PubMed ID: 8153655
    [No Abstract] [Full Text] [Related]

  • 20. [Origin of small cell lung cancers].
    Trillet-Lenoir V, Cordier JF.
    Rev Prat; 1993 Apr 01; 43(7):841-4. PubMed ID: 8394025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.